Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine CytotoxicityDAMARAJU, Vijaya L; SCRIVER, Tara; MOWLES, Delores et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 176-186, issn 1078-0432, 11 p.Article

Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma : Characterization of a novel nucleobase transport activityDAMARAJU, Deepti; DAMARAJU, Vijaya L; BRUN, Miranda et al.Biochemical pharmacology. 2008, Vol 75, Num 10, pp 1901-1911, issn 0006-2952, 11 p.Article

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicityPRADO, Carla M. M; LIMA, Isac S. F; BARACOS, Vickie E et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 93-101, issn 0344-5704, 9 p.Article

Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccineWEIMIN QI; SCHULTES, Birgit C; DAN LIU et al.Hybridoma. 2001, Vol 20, Num 5-6, pp 313-324, issn 0272-457XArticle

Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell culturesELWI, Adam N; DAMARAJU, Vijaya L; KUZMA, Michelle L et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 289-301, issn 0344-5704, 13 p.Article

Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3ELWI, Adam N; DAMARAJU, Vijaya L; KUZMA, Michelle L et al.American journal of physiology. Renal physiology. 2009, Vol 65, Num 6, issn 1931-857X, F1439-F1451Article